The Daily Debate - 3
Cell Therapy in Children
This year’s EBMT Paediatrics Day focused on hemoglobinopathies, and in particular sickle cell disease, which is now recognised by the UN and WHO as a global health problem, and their role as some of the first targets for new cellular therapies. We caught up with some leaders in paediatrics to talk about the multiple curative options, and some of the limitations and opportunities. Our experts were Prof. Selim Corbacioglu (Chair, EBMT Paediatric Diseases Working Party), Dr. Josu de la Fuente (Imperial College Healthcare NHS Trust) and Prof. Marina Cavazzana (Necker-Enfants Malades Hospital).